292 related articles for article (PubMed ID: 26035012)
21. The ISBER Self-Assessment Tool Indicates Main Pathways for Improvement in Biobanks and Supports International Standardization.
Betsou F
Biopreserv Biobank; 2018 Feb; 16(1):7-8. PubMed ID: 29359960
[No Abstract] [Full Text] [Related]
22. How Many Health Research Biobanks Are There?
O'Donoghue S; Dee S; Byrne JA; Watson PH
Biopreserv Biobank; 2022 Jun; 20(3):224-228. PubMed ID: 34582255
[No Abstract] [Full Text] [Related]
23. Transparency of Biobank Access in Canada: An Assessment of Industry Access and the Availability of Information on Access Policies and Resulting Research.
Gibson SG; Axler RE; Lemmens T
J Empir Res Hum Res Ethics; 2017 Dec; 12(5):310-325. PubMed ID: 28818009
[TBL] [Abstract][Full Text] [Related]
24. What Do Biomedical Researchers Want from Biobanks? Results of an Online Survey.
Rush A; Catchpoole DR; Reaiche-Miller G; Gilbert T; Ng W; Watson PH; Byrne JA
Biopreserv Biobank; 2022 Jun; 20(3):271-282. PubMed ID: 34756100
[No Abstract] [Full Text] [Related]
25. A Survey of the Current Situation of Clinical Biobanks in China.
Li H; Ni M; Wang P; Wang X
Biopreserv Biobank; 2017 Jun; 15(3):248-252. PubMed ID: 28080144
[TBL] [Abstract][Full Text] [Related]
26. Biobanks and Their Clinical Application and Informatics Challenges.
Yang L; Chen Y; Yu C; Shen B
Adv Exp Med Biol; 2016; 939():241-257. PubMed ID: 27807750
[TBL] [Abstract][Full Text] [Related]
27. 'Access arrangements' for biobanks: a fine line between facilitating and hindering collaboration.
Fortin S; Pathmasiri S; Grintuch R; Deschênes M
Public Health Genomics; 2011; 14(2):104-14. PubMed ID: 20689244
[TBL] [Abstract][Full Text] [Related]
28. Tensions Between Policy and Practice in Finnish Biobank Legislation.
Tupasela A
Biopreserv Biobank; 2015 Oct; 13(5):379-81. PubMed ID: 26418975
[TBL] [Abstract][Full Text] [Related]
29. Advancing Professionalization of Biobank Business Operations: Performance and Utilization.
Henderson MK; Goldring K; Simeon-Dubach D
Biopreserv Biobank; 2019 Jun; 17(3):213-218. PubMed ID: 31188630
[TBL] [Abstract][Full Text] [Related]
30. Biobank bootstrapping: is biobank sustainability possible through cost recovery?
Albert M; Bartlett J; Johnston RN; Schacter B; Watson P
Biopreserv Biobank; 2014 Dec; 12(6):374-80. PubMed ID: 25496148
[TBL] [Abstract][Full Text] [Related]
31. The State of Cloud-Based Biospecimen and Biobank Data Management Tools.
Paul S; Gade A; Mallipeddi S
Biopreserv Biobank; 2017 Apr; 15(2):169-172. PubMed ID: 28300421
[TBL] [Abstract][Full Text] [Related]
32. A Model to Estimate Frozen Tissue Collection Targets in Biobanks to Support Cancer Research.
Meredith AJ; Slotty A; Matzke L; Babinszky S; Watson PH
Biopreserv Biobank; 2015 Oct; 13(5):356-62. PubMed ID: 26418967
[TBL] [Abstract][Full Text] [Related]
33. [Quality management in biobank. World tendencies and experience of biobank of FSI «NMRC for preventive medicine» of the Ministry of healthcare of Russia.].
Pokrovskaya MS; Borisova AL; Sivakova OV; Metelskaya VA; Meshkov AN; Shatalova AM; Drapkina OM
Klin Lab Diagn; 2019; 64(6):380-384. PubMed ID: 31200412
[TBL] [Abstract][Full Text] [Related]
34. A Biobank's Journey: Implementation of a Quality Management System and Accreditation to ISO 20387.
Mouttham L; Garrison SJ; Archer DL; Castelhano MG
Biopreserv Biobank; 2021 Jun; 19(3):163-170. PubMed ID: 33147079
[TBL] [Abstract][Full Text] [Related]
35. The Significance of Biobanking in the Sustainability of Biomedical Research: A Review.
Zohouri M; Ghaderi A
Iran Biomed J; 2020 Jul; 24(4):206-13. PubMed ID: 32306718
[TBL] [Abstract][Full Text] [Related]
36. [Quality of biomaterials in liquid- and tissue-biobanking].
Herpel E; Schmitt S; Kiehntopf M
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):325-35. PubMed ID: 26753866
[TBL] [Abstract][Full Text] [Related]
37. Access to biobanks: harmonization across biobank initiatives.
Verlinden M; Nys H; Ectors N; Huys I
Biopreserv Biobank; 2014 Dec; 12(6):415-22. PubMed ID: 25496154
[TBL] [Abstract][Full Text] [Related]
38. Understanding public reactions to commercialization of biobanks and use of biobank resources.
Nicol D; Critchley C; McWhirter R; Whitton T
Soc Sci Med; 2016 Aug; 162():79-87. PubMed ID: 27343817
[TBL] [Abstract][Full Text] [Related]
39. Sustainability in Biobanking: Model of Biobank Graz.
Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
[TBL] [Abstract][Full Text] [Related]
40. Biobanking and Privacy Laws in Australia.
Chalmers D
J Law Med Ethics; 2015; 43(4):703-13. PubMed ID: 26711411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
